On good days, the immune system can effectively handle pathogens that invade the body. However, when foreign matter takes the upper hand, the body builds a wall of immune cells called granuloma around the pathogens to isolate ...
Dec 7, 2023
0
0
A team of CiRA researchers, building upon their previous work on differentiating iPS cells into kidney organoids, have made significant improvements to build a better model of kidney development and diseases for use as a ...
Dec 1, 2023
0
52
Jet lag is all in the mind. What exactly lags has more to do with the hypothalamus than the jet.
Nov 27, 2023
0
37
Epigenome editing is an emerging technology used to regulate gene function by controlling epigenetic states at specific locations on the genome. This method is distinct from traditional genetic editing, which involves permanently ...
Nov 6, 2023
0
0
An old campaign slogan for cough syrup, "It tastes awful. And it works," seemed to imply that any sweet content might have diminished the medicinal effect.
Oct 26, 2023
0
0
A joint effort by a team of academic and industrial researchers led by Associate Professor Yoshinori Yoshida (Department of Cell Growth and Differentiation) created a new modeling system, combining mechanical stretching and ...
Oct 18, 2023
0
40
Researchers have generated induced pluripotent stem cell (iPSC)-derived kidney organoids to model Alport syndrome caused by a mutation in the COL4A5 gene and have demonstrated the utility of a chemical chaperone to rescue ...
Oct 18, 2023
0
3
A research team has identified a potential new drug for interstitial lung disease, a condition affecting approximately 4.7 million people worldwide, and validated its protective effects using patient-specific induced pluripotent ...
Oct 12, 2023
0
6
A recent survey has identified differing opinions between the lay public and trained scientists on genome editing research using human embryos, which will help to guide future bioethical and policy discussions with the lay ...
Oct 12, 2023
0
13
A team of researchers led by Professor Megumu K. Saito have undertaken a massive effort to build an induced pluripotent stem (iPS) cell resource for rare diseases, enabling research and development of novel diagnostic tools ...
Oct 5, 2023
0
1
